Economic analysis of first-line treatment with erlotinib in an EGFR-mutated population with advanced NSCLC

Alain Vergnenegre, Bartomeu Massuti, Filippo De Marinis, Enric Carcereny, Enriqueta Felip, Pascal Do, Jose Miguel Sanchez, Luis Paz-Arez, Christos Chouaid, Rafael Rosell

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Economic analysis of first-line treatment with erlotinib in an EGFR-mutated population with advanced NSCLC'. Together they form a unique fingerprint.

Medicine & Life Sciences